Mysthera Therapeutics Company
Mysthera Therapeutics is a pharmaceutical company Mysthera plans to reshape the treatment landscape for autoimmune disease. PIM kinase inhibition uniquely and selectively modulates immune cell function in multiple lineages associated with complex disease.
Headquarters:
Basel, Basel-Stadt, Switzerland, Europe
Employee Number:
1-10
Industry:
Drug Discovery & Development
Founded Date:
2023-01-01
Super Industry:
Biopharma & Life Science Tools
Investors:
Forty51 Ventures
Ipo Status:
private
City:
Basel
Region:
Basel-Stadt
Country:
Switzerland
